DiaSorin S.p.A (DIA) - Medical Equipment - Deals and Alliances Profile

Date: April 24, 2018
Pages: 40
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: D07C9132E3FEN
Leaflet:

Download PDF Leaflet

DiaSorin S.p.A (DIA) - Medical Equipment - Deals and Alliances Profile
Summary

DiaSorin S.p.A. (DiaSorin) is a medical diagnostics company that develops, manufactures and markets in vitro diagnostics reagent kits and systems. The company develops reagent kits based on Radioimmunometry (RIA), Enzyme Linked Immunosorbent Assays (ELISA) and Chemiluminescence (CLIA) techniques, to enable automatic diagnostic investigation. The company’s products find application in the diagnosis of infectious diseases, bone and mineral disorders, endocrinology, hypertension, oncology, gastrointestinal infections, autoimmune disorders, and neurological and cardiac diseases. DiaSorin markets its products through direct sales force and distributors. It has operations in North America, South America, South Africa, EMEA and Asia. DiaSorin is headquartered at Saluggia, Piemonte, Italy.

DiaSorin S.p.A (DIA) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
  • The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
  • The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
  • Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
  • Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
  • Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company.

NOTE: Out of security concerns GlobalData requires using corporate email address.
DiaSorin S.p.A, Medical Equipment, Deals By Year, 2012 to YTD 2018
DiaSorin S.p.A, Medical Equipment Deals By Type, 2012 to YTD 2018
DiaSorin S.p.A, Medical Equipment, Deals By Region, 2012 to YTD 2018
DiaSorin S.p.A, Medical Equipment, Deals By Market, 2012 to YTD 2018
DiaSorin S.p.A, Medical Equipment, Deals Summary, 2012 to YTD 2018
DiaSorin S.p.A, Medical Equipment, Deal Details
Asset Purchase
DiaSorin Acquires ELISA Immunodiagnostic Business Portfolio from Siemens Healthcare for USD55.3 Million
DiaSorin Acquires Molecular and Immunoassay Product Business of Focus Diagnostics from Quest Diagnostics
Biotrin International Acquires Molecular Diagnostic Business Of NorDiag For US$10 Million
Partnerships
Evogen Enters Into Licensing Agreement With Focus Diagnostics For HyBeacons PCR Probe Technology
AbD Serotec Enters Into Licensing Agreement With DiaSorin For HuCAL Antibodies
DiaSorin Enters into Agreement with Tecan
DiaSorin Enters into Agreement with QIAGEN
DiaSorin Enters into Agreement with Beckman Coulter
DiaSorin Enters into Distribution Agreement with Beckman Coulter Diagnostics
Enzo Clinical Enters Into Collaboration Agreement With DiaSorin
DiaSorin Forms Joint Venture With Trivitron Healthcare
Asset Transactions
DiaSorin Acquires Molecular and Immunoassay Product Business of Focus Diagnostics from Quest Diagnostics
DiaSorin S.p.A - Key Competitors
DiaSorin S.p.A - Key Employees
DiaSorin S.p.A - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Financial Announcements
Nov 09, 2017: Growth In Revenues And Net Profit In Q3 2017. Strong Free Cash Flow Generation. 2017 Guidance Confirmed
Aug 03, 2017: Diasorin Group Reports Strong Growth in Revenues and Profitability in Q2 2017
May 08, 2017: Diasorin Group Reports Growth In Revenues And Profitability In The First Quarter 2017, Generating A Relevant Free Cash Flow
Mar 08, 2017: Net Profit And Cash Generation Reached Record Highs In 2016, Driven By Growth In Revenues And Profitability
Product News
Sep 26, 2017: DiaSorin Molecular Introduces Two Primer Pair Reagents for Streptococcus
Jul 28, 2017: Diasorin Launches 3 New Primer Pairs For Use In Molecular Testing: Pneumocystis Jirovecii, Group C Streptococcus, And Group G Streptococcus
Other Significant Developments
Jun 26, 2017: Diasorin Presents Its 2017-2019 Industrial Plan
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

DiaSorin S.p.A, Medical Equipment, Key Facts, 2016
DiaSorin S.p.A, Medical Equipment, Deals Summary, 2012 to YTD 2018
DiaSorin S.p.A, Medical Equipment, Deals By Year, 2012 to YTD 2018
DiaSorin S.p.A, Medical Equipment Deals By Type, 2012 to YTD 2018
DiaSorin S.p.A, Medical Equipment, Deals By Region, 2012 to YTD 2018
DiaSorin S.p.A, Deals By Market, 2012 to YTD 2018
DiaSorin S.p.A, Medical Equipment, Deals Summary, 2012 to YTD 2018
DiaSorin Acquires ELISA Immunodiagnostic Business Portfolio from Siemens Healthcare for USD55.3 Million
DiaSorin Acquires Molecular and Immunoassay Product Business of Focus Diagnostics from Quest Diagnostics
Biotrin International Acquires Molecular Diagnostic Business Of NorDiag For US$10 Million
Evogen Enters Into Licensing Agreement With Focus Diagnostics For HyBeacons PCR Probe Technology
AbD Serotec Enters Into Licensing Agreement With DiaSorin For HuCAL Antibodies
DiaSorin Enters into Agreement with Tecan
DiaSorin Enters into Agreement with QIAGEN
DiaSorin Enters into Agreement with Beckman Coulter
DiaSorin Enters into Distribution Agreement with Beckman Coulter Diagnostics
Enzo Clinical Enters Into Collaboration Agreement With DiaSorin
DiaSorin Forms Joint Venture With Trivitron Healthcare
DiaSorin Acquires Molecular and Immunoassay Product Business of Focus Diagnostics from Quest Diagnostics
DiaSorin S.p.A, Key Competitors
DiaSorin S.p.A, Key Employees
DiaSorin S.p.A, Subsidiaries

LIST OF FIGURES

DiaSorin S.p.A, Medical Equipment, Deals by Type, 2012 to YTD 2018
DiaSorin S.p.A, Medical Equipment, Deals By Year, 2012 to YTD 2018
DiaSorin S.p.A, Medical Equipment, Deals By Region, 2012 to YTD 2018
DiaSorin S.p.A, Medical Equipment, Deals By Market, 2012 to YTD 2018
DiaSorin S.p.A, Medical Equipment, Deals By Year, 2012 to YTD 2018
DiaSorin S.p.A, Medical Equipment, Deals by Type, 2012 to YTD 2018
DiaSorin S.p.A, Medical Equipment, Deals By Region, 2012 to YTD 2018
DiaSorin S.p.A, Medical Equipment, Deals by Market, 2012 to YTD 2018
Skip to top


Ask Your Question

DiaSorin S.p.A (DIA) - Medical Equipment - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: